허지윤 기자

Heo Ji-yoon Staff writer, ScienceChosun News Desk

Total articles(324)
Medical students end collective leave, face uncertainty in class participation
Medical students end collective leave, face uncertainty in class participation
The collective leave of absence by medical students, which has continued for over a year in protest against the medical school expansion policy, is expected to come to an end around the deadline for returning to school on the 31st. However, as the conflict between the government and the medical comm...
Korean pharmaceutical firms target Central and South America with strategic expansions
Domestic pharmaceutical and bio corporations as well as medical device corporations have successively entered the Central and South American market. The population of Central and South America reaches about 670 million, and the self-sufficiency rate of pharmaceuticals and medical devices is low, mak...
Lunit appoints Lee Jun-pyo as independent director to boost global strategy
Lunit held its 12th regular shareholder meeting at the Campco Yangjae Tower in Gangnam, Seoul, and announced on the 27th that it passed a total of seven agendas, including the appointment of independent director Lee Jun-pyo, as originally proposed. On this day, major agenda items, including the new ...
Seoul National University medical students register en masse, shift protest strategies
Following Yonsei University College of Medicine, students at Seoul National University College of Medicine decided to register en masse for the first semester by the deadline of the 27th. They have opted to avoid expulsion due to non-registration and have shifted their protest methods to 'register t...
South Korean youth struggle with low exercise rates, girls most affected
A survey found that the amount of physical activity, such as aerobic and strength training, among South Korean youth is still lower than that of youths in other countries. On the 27th, the Korea Disease Control and Prevention Agency analyzed the physical activity trends of adolescents (from middle s...
Global pharmaceutical firms leverage Chinese drug technology and approvals for growth
This year, Chinese corporations in the pharmaceutical and biotech sectors are exporting new drug technology to global pharmaceutical companies and obtaining drug approvals in the United States, achieving business results one after another. Despite the United States proposing the 'Biosecurity Act' to...
Yoon In-ho takes helm at Dongwha Pharm as CEO, leading fourth generation leadership
Yoon In-ho, the eldest son of Yoon Do-joon, chairman of Dongwha Pharm, has been promoted to president and CEO. Dongwha Pharm announced on the 26th that Yoon In-ho was promoted to president and CEO during a board meeting held after the shareholders' meeting. Accordingly, Dongwha Pharm changed to a du...
Lunar eclipse reveals blue band across moon, enhanced by atmospheric effects
What causes the blue band that crosses the moon during a lunar eclipse? This band is usually not very noticeable. This image was taken last week in Norman, Oklahoma, and was digitally enhanced. The gray part at the top right of the moon photo shows the moon's appearance, illuminated directly by Taey...
O Sang-hoon resigns as CHA Biotech CEO after six years of leadership
O Sang-hoon, CEO of CHA Biotech, will resign at the end of this month for personal reasons after leading the company for six years. According to CHA Biotech on the 25th, the board is expected to approve CEO O's resignation at the end of this month. Prior to that, O will hold an online video conferen...
John Lim tops Korea’s pharma salary chart with 7.9 billion won earnings
Last year, the 'salary king' in the domestic listed pharmaceutical and biotechnology industry was John Lim, CEO of Samsung Biologics. John Lim received a total of 7.9 billion won, including salary and bonuses (incentives). The second place went to Seo Jeong-jin, founder of Celltrion, and the third p...
  • 1
  • 2
  • 3
  • 4
  • 5
  • 6
  • 7
  • 8
  • 9
  • 10